Lonza in Japan
Address:
-
Office Lonza in Japan
9th floor, Nihonbashi Kato Building 1-14, Nihonbashi 2-chome, Chuo-ku Tokyo 104-6591
Phone: +81 3-6264-0600
Fax: +81 3 6264 0601
Other Lonza's locations around the world
Clinical Trials sponsored by Lonza
-
Lonza Ltd.DokončenoZdraví dobrovolníci | Zotavení | Endoteliální funkceNěmecko
-
Biofortis, Merieux NutriSciencesLonza Inc.Dokončeno
-
Biofortis, Merieux NutriSciencesLonza Inc.Dokončeno
-
KGK Science Inc.Lonza Inc.Dokončeno
-
Applied Science & Performance InstituteLonza Ltd.DokončenoSložení těla | Oxidační stres | Svalová síla | Poškození svalů | Odporový tréninkSpojené státy
-
Applied Science & Performance InstituteLonza Ltd.DokončenoOxidační stres | Bolest svalů | Svalová síla | Poškození svalů | Odporový tréninkSpojené státy
-
Applied Science & Performance InstituteLonza Ltd.DokončenoOxidační stres | Svalová síla | Poškození svalů | Odporový trénink | Potlačení imunitySpojené státy
-
Applied Science & Performance InstituteLonza Ltd.DokončenoSložení těla | Oxidační stres | Svalová síla | Poškození svalů | Odporový tréninkSpojené státy
-
Fred Hutchinson Cancer CenterLonza Walkersville, Inc.NáborStádium IV rakoviny slinivky břišní AJCC v8 | Metastatický duktální adenokarcinom slinivky břišníSpojené státy
About Lonza
Innovation lies at the heart of our mission to enable our customers to meet challenging deadlines and address their patients’ needs. Research & Development (R&D) plays a central role in how we approach innovation. It provides us with a long-term vision and ensures we make appropriate investments into extending our technology and capabilities to develop the tools we need for our future success.
Our scientific mindset, 360º view of industry trends and experience in transforming discovery into manufacturing applications, have been applied on multiple fronts throughout 2020. Our 14 R&D sites worldwide are an integral part of our global network and support innovation across the business.
Innovation does not happen in isolation. It is underpinned by strong synergies across all our R&D focus areas. Our R&D group is active in viral vectors, cell line construction, cell culture media, cell and gene therapies, capsule design and manufacturing, other oral dosage forms, chemical active pharmaceutical ingredients (APIs) and parenteral formulation and delivery. It is also involved in bio manufacturing and digital technology. Our key areas of interest are summarized here.